Sionna Therapeutics, Inc. Financial Overview
Sionna Therapeutics, Inc.'s market cap is currently $1.89B. The company's EPS TTM is $-0.46; its P/E ratio is -26.54; Sionna Therapeutics, Inc. is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
